The digital and trustworthy evidence ecosystem: how can health industry players join to increase value in health care and capture a global market?

Similar documents
New methods, how could Norway speed up Health Technology Assessment (HTA) to the benefit of health industry, policy-makers, clinicians and patients?

Advances and Perspectives in Health Information Standards

Andalusian Agency for Health Technology Assessment (AETSA)

National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs

Translational scientist competency profile

Adopting Standards For a Changing Health Environment

'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint

TWO BY TWO: A METHODOLOGICAL PERSPECTIVE ON THE USE OF EVIDENCE TO SUPPORT THE VALUE OF A HEALTH TECHNOLOGY

Issues in Emerging Health Technologies Bulletin Process

Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities

Virtual Clinical Trials: Challenges and Opportunities

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Biomedical Innovation Has Science Overtaken the System?

Finn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark

#IGResearch16. Professor Paul Nightingale Deputy Director, Science Policy Research Unit University of Sussex

National Commercial Bank. Digital Symposium City Lights by Morris Taylor

EMA experience with the review of digital technology proposals in medicine development programmes

Universities and Sustainable Development Towards the Global Goals

Tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases

Alberta Health Services and Advancing Uptake of HTA & Innovation

National Coordinated Registry Network (CRN) Think-tank

SHTG primary submission process

Powered by: Norway for Life Science. Photo cover: Christopher Olssøn Design: Fete typer

Robotics in Horizon 2020 ICT Work Programme

Health & Social Care Industrial Innovation

Contents. In-Body Hospital isnʼt a dream - Expectations towards Japanʼs future leaders, COINS. COINS - A New Open Innovation Platform

EU s Innovative Medical Technology and EMA s Measures

International experiences in mobilizing knowledge to improve health systems

Magnus Steigedal Director NTNU Health NTNU

Driving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif

CLEAN ENERGY FOR GREEN GROWTH INVEST / LEARN / SHARE

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Reduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?

Model Based Design Of Medical Devices

Centre for Healthcare Technologies

Digital Medical Device Innovation: A Prescription for Business and IT Success

Industrial Strategy Challenge Fund. Dr Jon Wood Manager for

December Eucomed HTA Position Paper UK support from ABHI

Health Technology Assessment (HTA): A Primer for Procurement Professionals

IMI2 Intellectual Property rules in light of Call 10 topics. Magali Poinot, IMI Legal Manager IMI Stakeholder Forum 28 September 2016

An Essential Health and Biomedical R&D Treaty

Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

EU Research Integrity Initiative

Helping your business grow in the UK health system

Navigating the Healthcare Innovation Cycle

Life sciences road map pathway to a national strategy

Implementation of Systems Medicine across Europe

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation

Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use

SURGERY STRATEGIC CLINICAL NETWORK EVIDENCE DECISION SUPPORT PROGRAM. New ideas & Improvements

Asia Conference Singapore

Promoting Patient and Researcher Engagement with Distributed Data Research Networks through Hurdle Free Tools

Health Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI

CONSTRUCTION MACHINES IN THE DIGITAL AGE CONSTRUCTION EQUIPMENT MAKERS NEED TO FIND THEIR PLACE IN SMART BUILDING SITES. Romed Kelp and David Kaufmann

WFEO STANDING COMMITTEE ON ENGINEERING FOR INNOVATIVE TECHNOLOGY (WFEO-CEIT) STRATEGIC PLAN ( )

Innovative Business Incubation Foster the Growth of Technology

MEDITECH-endorsed solution for HL7 data exchange

IT and Systems Science Transformational Impact on Technology, Society, Work, Life, Education, Training

Implementation in the Multilevel Context of Routine Practice and Policy

The Reproducible Research Movement in Statistics

Vanderbilt University Medical Center

Ethical issues raised by big data and real world evidence projects. Dr Andrew Turner

Health technology translation from lab to market from the perspective of Diagnostics (Dx) Innovator

HTA in Norway- HTA - international challenges

CADTH HEALTH TECHNOLOGY MANAGEMENT PROGRAM Horizon Scanning Products and Services Processes

Managing Conflict of Interest

A Vision for Government in a Digital World

THANK YOU FOR JOINING ISMPP U TODAY!

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry

A review of the role and costs of clinical commissioning groups

EU Cooperation on Health Technology Assessment

Health Technology Assessment of innovative medical devices

Article 117 A Notified Body perspective, advice on how and when to engage notified bodies

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

Clinical Open Innovation

AlaskaNor: Opportunities for Blue Growth in Alaska & North Norway. High North Center for Business and Governance, Nord University

Shared Investment. Shared Success. ReMAP Call for Proposals by Expression of Interest

FP6 assessment with a focus on instruments and with a forward look to FP7

Bringing Technology and Product Development Best Practices Together for Successful Innovation

Digital Reality TM changes everything

SUMMARY EDITORIAL PULSE PLATFORM COMPONENTS. PULSE Newsletter. Editorial and Platform Components

TOURISM INSIGHT FRAMEWORK GENERATING KNOWLEDGE TO SUPPORT SUSTAINABLE TOURISM. IMAGE CREDIT: Miles Holden

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

Decision Support System EBMeDS. Timo Haikonen

Re-engineering Collaborative Mechanisms and Knowledge Networks to Accelerate Innovation for Alzheimer s

Parkinson s World A transformational project by The Cure Parkinson s Trust

EU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson

Ken Buetow, Ph.D. Director, Computation Science and Informatics, Complex Adaptive ASU Professor, School of Life Science

The Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine s Computer Age

INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS. MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013

Telehealth and Digital Technology. Libbe Englander, PhD

Visualization of Systems and Stakeholders in Health Care Innovation by means of a Multilevel Design Model

Health Care Analytics: Driving Innovation

Higher Education Contribution to Health Science Innovation

Founder healthtech-ux Chief HIS Manager, Mercy Public Hospitals Inc. Associate Professor (Adjunct)-Monash University, Faculty of IT

The Passion Project TM Business Launch Blueprint

Security and Risk Assessment in GDPR: from policy to implementation

POWERING THE GLOBAL ENERGY DEMAND

Opportunity now: Europe s mission to innovate

Transcription:

The digital and trustworthy evidence ecosystem: how can health industry players join to increase value in health care and capture a global market? Per Olav Vandvik, Professor of Medicine, University of Oslo and Norwegian Institute of Public Health Disclosures: Head of MAGIC (non-profit), BMJ Rapid Recommendations and the Evidence Ecosystem project 1

Meet Jon with cryptogenic stroke, in need of a new device? How can these two make a well- informed decision? Doc: Should I close the hole in my heart? 2

How can clinicians find best current evidence < 2 minutes? 3

Trustworthy recommendation just published 4

Take home messages/ objectives for this talk PFO closure device companies got it right! How can you succeed in demonstrating benefits of devices and drugs to increase value in health care, while reaching the global market? Get the question right, and make sure it s a good one Perform the research to demonstrate value and to fully inform downstream decisions by policy-makers, clinicians and patients Understand advances in standards, methods, processes and tools within an emerging digital and trustworthy evidence ecosystem for health care Help improve the evidence ecosystem for mutual benefits 5

Health industry is blooming with new devices and drugs, personalized medicine through genomics and Big Data : Are we creating value? 6

Reasons to be concerned (about the $ 400 billion medical device industry)? 7

All good for drugs? 8

Major advances for EBM, systematic reviews and guidelines in standards, methods and tools, but what about technology? 9 9

Problems with guidelines: Can technology help? Platforms and tools ready for use (e.g., www.magicapp.org) 10

Multilayered guidelines in digitally structured formats plugged into any information resource, ready for adaptation 11

Challenges beyond guidelines, for patients and society 12

Problems in current Evidence Ecosystem, spelled out Ouch: Health industry actors left out of the picture 13

Health industry blooming but struggling to create valuable products and take the market How can we accelerate product development, evaluation and implementation 14 in health care at the global level?

Solutions, to increase value and reduce waste in health care and research How can the Health industry join to enhance the emerging Evidence Ecosystem? 15

Some hurdles to overcome: Organizations fit for purpose? BMJ Rapid Recommendations, a disruptive innovation? 16

BMJ Rapid Recommendations, speeding up evidence synthesis and guidance dissemination 17

What can we learn from the PFO closure device story? 18

How can we help in the Evidence Ecosystem? and what does the future hold? Synthesized new evidence 2018: High quality systematic review confirms large benefit on stroke reduction Practice-changing evidence 2017-18: 4 new trials on PFO-closure BMJ RapidRecs enhancing the Evidence Ecosystem Disseminated guidance August 2018: BMJ RapidRecs strongly recommends PFOclosure Fall 2018: Norwegian HTA + national guideline update Implementation and evaluation of impact Winter 2019: CDS in EHR, national stroke registry And local quality improvement projects in hospitals

What do we do with new technologies who got it wrong? 20

Evidence Ecosystem reducing waste Sweden using real-world evidence in SwedeHeart registry 21

Registry-based trial closing the loop, with real world evidence changing practice worldwide 22

In summary and for discussion Health industry blooming but struggling to demonstrate benefits of devices and drugs to increase value in health care while reaching the global market You can succeed if you: Get the question right, and make sure it s a good one Perform the research to demonstrate value and to fully inform downstream decisions by policy-makers, clinicians and patients Understand advances in standards, methods, processes and tools within an emerging evidence ecosystem for health care Are better supported by health care actors in a joint effort to improve the evidence ecosystem, for mutual benefits 23